Schizophrenic clients who are unresponsive to conventional antipsychotic drugs may be helped by which drug?

Schizophrenic clients who are unresponsive to conventional antipsychotic drugs may be helped by which drug?

• A. Chlopromazine
• B. Valium
• C. Benadryl
• D. Clozaril

Answer: (D)

When schizophrenia does not respond to standard antipsychotics, a different type of antipsychotic that targets multiple neurotransmitter systems can be effective. Clozapine is the standout in this situation because it has proven efficacy in treatment-resistant schizophrenia and can also reduce the risk of suicidality in this population. It works by blocking dopamine receptors like other antipsychotics, but also affects serotonin receptors, which helps address both positive and negative symptoms more effectively for some patients. However, this benefit comes with important safety requirements. Clozapine carries a serious risk of agranulocytosis (a dangerous drop in white blood cells), so patients must have regular blood tests to monitor white blood cell counts. This monitoring is essential and ongoing, making clozapine a carefully managed option reserved for those who do not respond to conventional therapies. Other choices listed are not effective for treatment-resistant schizophrenia: a typical antipsychotic like chlorpromazine has higher extrapyramidal side effects and may be less effective in resistant cases, while a benzodiazepine or an antihistamine does not treat the psychosis itself.

When schizophrenia does not respond to standard antipsychotics, a different type of antipsychotic that targets multiple neurotransmitter systems can be effective. Clozapine is the standout in this situation because it has proven efficacy in treatment-resistant schizophrenia and can also reduce the risk of suicidality in this population. It works by blocking dopamine receptors like other antipsychotics, but also affects serotonin receptors, which helps address both positive and negative symptoms more effectively for some patients.

However, this benefit comes with important safety requirements. Clozapine carries a serious risk of agranulocytosis (a dangerous drop in white blood cells), so patients must have regular blood tests to monitor white blood cell counts. This monitoring is essential and ongoing, making clozapine a carefully managed option reserved for those who do not respond to conventional therapies. Other choices listed are not effective for treatment-resistant schizophrenia: a typical antipsychotic like chlorpromazine has higher extrapyramidal side effects and may be less effective in resistant cases, while a benzodiazepine or an antihistamine does not treat the psychosis itself.